CALL TO PUBLIC ACTION AGAINST NOVARTIS IN NYC
Novartis has been attacking India’s patent law for six years, and if it wins, it could change the way drugs are patented in India, which would restrict the production of more affordable generic versions of drugs. Eighty percent of the medicines MSF uses to treat 170,000 people living with HIV in its projects today are sourced from Indian generic drug companies. The case is before India’s Supreme Court – the hearings start on 28th Feb.
Now it is time for us to join and support our colleague’s actions here in New York. We will be joining activists from Health GAP on Wednesday to protest Novartis’ case ahead of the company’s shareholder meeting.
Where? Novartis Corporation Corporate Communications
230 Park Avenue (between 46th & 45th)
New York, NY 10169
When? Wednesday, February 22, 2012 - 11:30 AM
New York, NY
What? Join activists to protest the Novartis case.
OTHER ACTIONS YOU CAN TAKE:
Please sign and share this online petition
MSF’s Access Campaign has been in New Delhi working with Indian civil society groups to rally public support against Novartis’ case. Marches and press conferences are being organized in Mumbai near the Novartis India office for the week of February 28 to coincide with the Indian Supreme Court hearing.
Health GAP and ACT UP activists will be mobilizing Wednesday in Boston outside Novartis’ US office as well.
Photo:India 2007 © MSF